Emcure Pharmaceuticals Ltd.
Research Emcure Pharmaceuticals Ltd. (EMCURE.NS) on Bullrun: market cap INR 345.39B, P/E 34.1, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEMCURE.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 345.39B
- P/E34.1
- Dividend yield0.2%
- Financial periodQ2 2026
- RevenueINR 25.80B
- Net incomeINR 2.94B
- Gross margin58.4%
Valuation Snapshot
latest market cap is INR 345.39B; P/E is 34.1; dividend yield is 0.2%.
Peer valuation comparison
Latest P/E is 34.13x versus a Healthcare sector median of 21.74x (56.9% above).
Latest dividend yield is 0.2% versus a Healthcare sector median of 2.4% (91.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 345.39B | 34.1 | 0.2% | 3.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.6 INR, yield 0.2%.
About Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynaecology, cardiovascular, blood-related, pain and analgesics, oncology/anti-neoplastics, anti-infectives, vitamins, minerals and nutrients, respiratory, HIV antivirals, Metabolics, gastro, anti-diabetic, neuro, derma, and mRNA vaccine.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Emcure Pharmaceuticals Ltd.'s market cap?
Emcure Pharmaceuticals Ltd.'s market capitalization is INR 345.39B.
What is Emcure Pharmaceuticals Ltd.'s P/E ratio?
Emcure Pharmaceuticals Ltd.'s price-to-earnings (P/E) ratio is 34.1.
Does Emcure Pharmaceuticals Ltd. pay a dividend?
Emcure Pharmaceuticals Ltd. has a dividend yield of 0.2%.
What does Emcure Pharmaceuticals Ltd. do?
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynaecology, cardiovascular, blood-related, pain and analgesics, oncology/anti-neoplastics, anti-infectives, vitamins, minerals and nutrients, respiratory, HIV antivirals, Metabolics, gastro, anti-diabetic, neuro, derma, and mRNA vaccine.